ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
David J. Cohen
Harold D. Head
Geoffrey M. Graeber
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baker, J. R.
Right arrow Articles by Graeber, G. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baker, J. R., Jr.
Right arrow Articles by Graeber, G. M.

Ann Thorac Surg 1986;41:507-510
© 1986 The Society of Thoracic Surgeons

Articles

Development of Circulating Antiheart Antibodies as a Result of Coronary Bypass Surgery

James R. Baker, Jr., M.D., MAJ, MC, USA, David J. Cohen, M.D., LTC, MC, USA, Harold D. Head, M.D., COL, MC, USA, James L. DeShong, Sp5, USA, Geoffrey M. Graeber, M.D., LTC, MC, USA*

Departments of Transplant Immunology and Thoracic Surgery, Walter Reed Army Medical Center, the Division of Surgery, Walter Reed Army Institute of Research, Washington, DC, and the Department of Surgery, The Uniformed Services University of the Health Sciences, Bethesda, MD

Accepted for publication July 29, 1985.

* Address reprint requests to Dr. Graeber, Division of Surgery, Walter Reed Army Institute of Research, Walter Reed Army Medical Center, Washington, DC 20307-5100

Antiheart antibodies have been implicated as a marker of postcardiotomy syndrome in patients undergoing coronary artery bypass. To assess the frequency of and contributory factors in the development of antiheart antibodies after coronary bypass procedures, 33 patients were examined for evidence of antiheart antibodies before and for seven days after routine coronary artery bypass operations. Overall titers of antiheart antibodies rose in approximately 66% of the patients. However, this rise was not accompanied by any major clinical symptoms. History of previous myocardial infarction or myocardial injury did not correlate with a higher frequency of development of antibodies. Antiheart antibodies appear to be a common consequence of coronary artery bypass operations and are not routinely associated with the development of postcardiotomy syndrome.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1986 by The Society of Thoracic Surgeons.